Authors
Latest:
Medical Gaslighting: Multiple Sclerosis’ Dirty Little Secret?The effect of gaslighting on patients can result in serious harms, and although it is potentially common in the MS care continuum, whether it is deliberate or an institutional problem, it must be called out by providers.
Latest:
Post-Stroke Seizure Predictive Models, SeLECT Model: Carolina Ferreira Atuesta, MD, MScThe scientific researcher and clinical manager, Icahn School of Medicine at Mount Sinai, spoke about the clinical models used to predict seizures in poststroke patients. [WATCH TIME: 4 minutes]
Latest:
Understanding Treatment Benefit of Once-Nightly Sodium Oxybate in Narcolepsy Types 1 and 2: Jennifer Gudeman, PharmDThe senior vice president of medical and clinical affairs for Avadel Pharmaceuticals provided commentary on recently published research supporting once-nightly sodium oxybate (Lumryz) in narcolepsy regardless of the subtype. [WATCH TIME: 5 minutes]
Latest:
Improving PAP Adherence in Younger Patients With OSA: William Noah, MDThe director and founder of the Sleep Centers of Middle Tennessee discussed trends in positive airway pressure adherence that his center’s research has revealed.
Latest:
Stroke Prevention and Atrial Fibrillation Management, Thoughts From STROKE-AF Study: Lee Shwamm, MDThe professor of neurology at Harvard Medical School spoke at the 2023 ISC Conference about highlights from the STROKE-AF study after a 3-year follow-up. [WATCH TIME: 5 minutes]
Latest:
Mechanism of Stem Cell Therapy Bemdaneprocel for Parkinson Disease: Amit Rakhit, MDThe chief medical officer and chief development officer at BlueRock Therapeutics discussed the promise behind bemdaneprocel and its unique mechanism of action relative to other Parkinson disease treatments. [WATCH TIME: 3 minutes]
Latest:
Closing Thoughts on 2024 AUPN Annual MeetingThe meeting with the American Neurologic Association fosters collaboration, networking, and joint sessions, enhancing knowledge sharing among academic neurologists.
Latest:
Importance of Evaluating Real-World Populations in MS: Allitia DiBernardo, MDThe global head of medical affairs-neurology at Janssen Pharmaceutical provided background on the need for real-world studies and how they can accurately portray a disease community.
Latest:
Advice for Managing Dravet Syndrome and LGSMary Anne Meskis; Tracy Dixon-Salazar, PhD; Kelly Knupp, MD; and Joseph E. Sullivan, MD, provide advice for physicians treating patients with Dravet syndrome or LGS.
Latest:
Combining Brain-Computer Interface with Augmented Reality for Neurodegenerative Diseases: Andreas ForslandThe chief executive officer of Cognixion talked about the Cognixion ONE Axon, a wireless, wearable brain-computer interface that combines EEG technology with an augmented reality headset for patients with neurodegenerative diseases. [WATCH TIME: 4 minutes]
Latest:
Retinal Vasculature Changes in Migraine With Aura: Katherine Podraza, MD, PhDThe headache specialist at the Hartford Healthcare Headache Center discussed findings from a study that revealed altered retinal vasculature in individuals with migraine with aura, indicating potential retinal biomarkers for disease progression. [WATCH TIME: 4 minutes]
Latest:
Both Sides Now: The Before and After of CIDP’s Diagnostic JourneyCrystal, a patient living with chronic inflammatory demyelinating polyneuropathy and one of the faces of the Shining Through CIDP awareness campaign, discussed the diagnostic challenges associated with the rare disease.
Latest:
2024 Clinical Preview for Emerging Trends in Sleep Disorders: Mark I. Boulos, MD, BSc, FRCP, CSCN, MScThe associate professor, department of medicine, division of neurology, Institute of Medical Science, University of Toronto, shared his thoughts on potential therapies and expanding care options for sleep disorders in 2024. [WATCH TIME: 5 minutes]
Latest:
Where Are We: Development of Gene and Cell Approaches for Parkinson DiseaseAccording to recent studies and the latest insights provided by experts, early developments in gene and cell therapies show promise for patients living with Parkinson disease, but challenges remain.
Latest:
Search for Targeted Therapies for Primary Headaches Beyond Migraine: Jihan A. Grant, MDThe director of headache medicine at The Mount Sinai Hospital talked about the often-overlooked realm of primary headaches beyond migraines as well as the importance of developing targeted treatments and increasing understanding of their pathophysiology. [WATCH TIME: 7 minutes]
Latest:
Improving Diagnosis, Screening Patients More Efficiently in Alzheimer Disease: Katherine Turk, MDThe behavioral neurologist at VA Boston Healthcare System talked about screening patients for mild cognitive impairment to improve diagnosis in Alzheimer disease at the 2023 AAN Annual Meeting. [WATCH TIME: 5 minutes]
Latest:
Practice Pearls for Management of NMOSDExperts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.
Latest:
Tools for Cultivating Meaning This Holiday SeasonWhat excites you? What awakens your sense of purpose? What gives your life meaning? Bradley McDaniels, PhD, CRC, explores the importance of meaning in one's life.
Latest:
AUPN Leadership Minute Episode 28: Leadership to Effect ChangeEpisode 28 of the AUPN Leadership Minute features Donald S. Higgins, MD, of the VHA; and Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, of University of Oxford. [WATCH TIME: 5 minutes]
Latest:
Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MDThe medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]
Latest:
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s DiseaseDrs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Latest:
Efficacy and Safety of Weekly Subcutaneous Efgartigimod for Myasthenia Gravis: Yuebing Li, MD, PhDThe neuromuscular neurologist at the Cleveland Clinic discussed findings from an analysis presented at AANEM 2023 that investigated the safety and efficacy of subcutaneous efgartigimod in patients with myasthenia gravis. [WATCH TIME: 5 minutes]
Latest:
Sleep Disturbances and Recovering From Alcohol Use Disorder: Garth T. Whiteside, PhDThe head of preclinical development at Imbrium Therapeutics provided an overview of positive safe and efficacy findings from the phase 2 study investigating sunobinop. [WATCH TIME: 4 minutes]
Latest:
Streamlining Stroke Rehab Systems in Common Clinical Care: Eric Leuthardt, MDThe founder and chief scientific officer of Neurolutions discussed complexities within the system to integrate new stroke rehab devices.
Latest:
Promising Disease-Modifying Therapies in Parkinson DiseaseDespite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Latest:
Reimaging the Approach to Treating Alzheimer Agitation: Sube Banerjee, MD, MSc, MBA, FRCPsychThe professor of dementia and executive dean of the Faculty of Health at the University of Plymouth provided perspective on the way to attack Alzheimer agitation and why drug solutions often fall short. [WATCH TIME: 3 minutes]
Latest:
Talking Transitional Readiness for Teens With Multiple Sclerosis: Vikram Bhise, MDThe associate professor of pediatrics and neurology at Rutgers–Robert Wood Johnson Medical School commented on the need to recognize when adolescent patients are ready to learn more about their condition. [WATCH TIME: 5 minutes]
Latest:
AUPN Leadership Minute Episode 39: Supporting K AwardeesEpisode 39 of the AUPN Leadership Minute features Donald S. Higgins Jr, MD, of Veterans Health Administration, Albany Medical College; and Alexandra Nelson, MD, PhD, of the University of California San Francisco. [WATCH TIME: 5 minutes]
Latest:
The Complexities of Alzheimer Disease Treatment and Diagnosis in Clinical Trials: Sharon L. Rogers, PhDThe chief executive officer at AmyriAD Therapeutics discussed the limitations of clinical trials assessing potential disease-modifying therapies for Alzhiemer disease including the lack of a diverse patient population and nonthorough clinical assessments for diagnosis. [WATCH TIME: 6 minutes]
Latest:
Insights Into Nasal Pathways for Brain Protein Sampling and Treatment Delivery: Mony de Leon, EdDThe director of the Brain Health Imaging Institute in the department of radiology at Weill Cornell Medicine talked about exploring nasal pathways as an alternative for brain protein sampling and drug delivery. [WATCH TIME: 4 minutes]
